MONTCLAIR, N.J., July 25, 2018 /PRNewswire-PRWeb/ -- At PAINWeek 2018, the program agenda will be augmented with 4 registration-only,
Cannabis and Cannabinoids: Kissing Cousins or Good Cop/Bad Cop? An exploration of the scientific evidence that supports or refutes the use of cannabinoids, including clinical pharmacology, acute and chronic adverse effects, and the appropriate use of FDA-approved and other cannabinoids. Offering a commonsense approach to a complicated topic, the workshop will be presented on Tuesday morning, September 4.
On Tuesday afternoon, Patient Centered Opioid Reduction will introduce critical behavioral and medical aspects of an evidence-based patient centered approach to voluntary opioid reduction, including transforming the messaging in the clinic environment, using the right approach and language, partnering with patients, setting them up for success with a tapering schedule, and helping patients feel and be in control. Both provider-level and clinic-level strategies will be discussed.
Working With Old Molecules: Lipstick on the Pig...or Mama's Got a Brand New Bag, scheduled for Wednesday morning, September 5, will address critical issues with monitoring and dosing methadone, including risk stratification for candidate selection, the implication of drug interactions, and the nuances of monitoring. Buprenorphine's intriguing pharmacology will be covered, along with dosing guidance for chronic pain.
The Palliative Care Bootcamp on Saturday, September 8, is a full-day program of clinical pearls on the management of pain and nonpain symptoms associated with advanced illness. Participants will learn how to conduct a thorough assessment of pain in a verbal and nonverbal patient and how to use this information to determine the most likely pathogenesis of pain, which drives drug-therapy decision making. The use of ketamine, methadone, and lidocaine will be addressed.
Senior PAINWeek faculty members Douglas Gourlay, MD, MSC, FRCPC, FASAM, and Mary Lynn McPherson, PharmD, MA, MDE, BCPS, CPE, will lead the workshop on cannabis and cannabinoids. Dr. Gourlay commented: "I look forward to joining Dr. McPherson in detailing what we know—and what we don't know—about medical cannabis and cannabinoids, and the challenges confronting prescribers who are being asked to recommend marijuana for their patients with pain. It's a complicated topic from both a regulatory and therapeutic perspective, and we hope to offer workshop participants a commonsense approach to follow."
To maximize the workshop experience, attendance will be limited, and early registration is encouraged. Please go here to register and learn more.
About PAINWeek: PAINWeek, the largest US pain conference for frontline clinicians with an interest in pain management, will convene for its 12th annual meeting on September 4-8 at the Cosmopolitan of Las Vegas. The conference presents 120+ hours of continuing medical education courses and master classes, special interest sessions, and satellite events. Over 2,300 practitioners are expected to attend.
PAINWeek is provided by Global Education Group. About Global Education Group: Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.
Subscribe to our Free Newsletters!